{"text": "TITLE:\n      Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System\nSUMMARY:\n      The QuickClose Design 9 is a prospective, non randomized study, to evaluate the safety and\n      efficacy of the QuickClose design 9 closure device.\n      patient undergoing a diagnostic or therapeutic angiogram procedure will be treated with the\n      QuickClose Design 9. Patients will be monitored until 30 days after the procedure.\nDETAILED DESCRIPTION:\n      the primary safety endpoint is the incidence of major complications related to method for\n      achieving hemostasis at the puncture site. the secondary safety endpoints is the incidence\n      of minor complications related to method for achieving hemostasis at the puncture site. the\n      primary efficacy endpoints are time to hemostasis, time to ambulation and time to discharge.\n      the secondary efficacy endpoints are device and procedure success\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  patient/legal representative provides written informed consent\n          -  Patient is scheduled for a coronary or peripheral diagnostic or interventional\n             procedure\n          -  Target vessel has a lumen diameter \u2265 6 mm\n          -  Patient must be willing to comply with follow-up requirements\n          -  Patient has a 5-7F arterial puncture located in the common femoral artery\n        Exclusion Criteria:\n          -  Arterial puncture in the femoral artery of both legs\n          -  Manual compression has been preformed on the ipsilateral arterial site within the\n             previous 6 weeks\n          -  Any closure system has been used on the ipsilateral arterial site within the previous\n             180 days\n          -  Any reentry of the ipsilateral site is planned within the next 6 weeks\n          -  History of surgical repair of blood vessels of the ipsilateral arterial site\n          -  Patient is unable to ambulate at baseline\n          -  Significant bleeding diathesis or platelet dysfunction\n               1. Thrombocytopenia (Plt count \u2264 100,000)\n               2. Anemia (Hgb \u2264 10mg/dl and/or Hct \u2264 30mg/dl)\n               3. Hemophilia\n               4. Von Willebrand\"s disease\n               5. Thrombophilia (i.e. factor 5 deficiency or other)\n          -  ST-elevation myocardial infarction \u2264 48 hours prior to the cardiac or peripheral\n             catheterization procedure\n          -  Pre-existing severe non-cardiac systemic disease or pre-existing terminal illness\n          -  Pre-existing systemic or cutaneous infection\n          -  Receiving warfarin therapy within the last 14 days.\n          -  INR results > 1.2 on day of procedure for any patient with a history of warfarin\n             therapy\n          -  Thrombolytic therapy (e.g. streptokinase, urokinase, t-PA) \u2264 24 hours prior to the\n             cardiac or peripheral catheterization procedure\n          -  Concurrent participation in another investigational device or drug trial\n          -  Angiomax (bivalirudin) or other thrombin-specific anticoagulants or low molecular\n             weight heparin \u2264 24 hours prior to the cardiac or peripheral catheterization\n             procedure\n          -  Planned arterial access at the same access site \u2264 30 days following the femoral\n             artery closure procedure\n          -  Evidence of a preexisting hematoma, arteriovenous fistula, or pseudoaneurysm at the\n             access site prior to start of femoral artery closure procedure\n          -  Prior femoral vascular surgery or vascular graft in region of access site or\n             contralateral common femoral artery\n          -  Symptomatic leg ischemia in the target vessel limb including severe claudication or\n             weak/absent pulse\n          -  Absent of pedal pulse on ipsilateral side\n          -  Pre-existing autoimmune disease\n          -  BMI > 40 kg/m2\n          -  The targeted femoral artery is tortuous or requires an introducer sheath length > 11\n             cm\n          -  Fluoroscopically visible calcium, atherosclerotic disease, or stent \u2264 1 cm of the\n             puncture site that would interfere with the placement of the VCD's plug\n          -  Suspected bacterial contamination of access site\n          -  Puncture through a vascular graft\n          -  Double wall puncture\n          -  Antegrade puncture\n          -  Palpable Hematoma\n          -  Difficulty in obtaining vascular access resulting in multiple arterial punctures\n             and/or posterior arterial puncture\n          -  Any Arterial and/or Venous access on the ipsilateral or contralateral groin other\n             than target study access site\n          -  Patient is not cooperative\n          -  Intra-procedural therapeutic thrombolysis is preformed\n          -  Uncontrolled hypertension at time of sheath removal (blood pressure \u2265 170 mmHg\n             systolic and/or \u2265 100mmHg diastolic)\n          -  Peripheral vascular disease on the ipsilateral arterial vessel (\u2265 50% stenosis) or\n             aneurismal disease of this vessel.\n          -  Sheaths has been changed during the procedure\n          -  Heparinized patients with elevated pre-closure ACT level\u2265 300 seconds\n          -  Patient has known allergy to any materials used in the VCD\n          -  Patient is known to require an extended hospitalization (e.g. patient is undergoing\n             CABG surgery)\n          -  Prior or recent use of an intra-aortic balloon pump through the arterial access site\n          -  Cardiogenic shock (hemodynamic instability requiring intravenous medications or\n             mechanical support) experienced during or immediately post-catheterization\n          -  Patient is known or suspected to be pregnant, or is lactating\n          -  Patient has known allergy to contrast medium\n          -  Any angiographic or clinical evidence that the investigator feels would place the\n             patient at increased risk with the use of the VCD\n          -  Required simultaneous ipsilateral or contralateral venous puncture\n", "cuis": "C0015801 C0226455 C0019120 C0180950 C1590112 C0185003 C1515974 C1546778 C1552616 C1706244 C0947630 C0220825 C0002978 C1548816 C3891555 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0087111 C0723712 C0723719 C1547427 C0011900 C0358514 C0430022 C1547424 C0332155 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C3842337 C0030695 C0150369 C0181904 C0678257 C0033080 C1521941 C0009566 C1171258 C0802632 C0161768 C0236167 C1148100 C0025663 C0025664 C0233492 C0445356 C0740166 C0027627 C0034117 C0033119 C0009566 C1171258 C0802632 C0161768 C0236167 C1148100 C0740166 C0034117 C0033119 C0025663 C0025664 C1446899 C0233492 C0445356 C0740166 C0945826 C0012621 C0030685 C0600083 C1546601 C2926602 C0027627 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0243161 C0013893 C0243161 C0009797 C0973449 C1555587 C2183254 C1948041 C0886296 C2183253 C2183257 C0018787 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0086960 C0011900 C0358514 C0430022 C1547424 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0449618 C3842086 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0600109 C0558080 C0556050 C0189586 C1548740 C0176674 C0015801 C1280173 C0226448 C1281581 C0226455 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C3245511 C0243161 C0189586 C1548740 C0176674 C0015801 C1280173 C0226448 C1281581 C0226455 C1140621 C0565514 C0021153 C1829459 C4049863 C0024763 C3891067 C0003842 C0155668 C0003842 C0374711 C0567345 C0005847 C1283786 C0262926 C2004062 C0003842 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C1299582 C4036205 C0728774 C0679429 C1720669 C0005779 C1458140 C0040034 C1839163 C1861185 C2677608 C2678311 C0858535 C1856453 C0002871 C0018935 C0019069 C0684275 C0008533 C0015523 C0740130 C0012634 C0018609 C0042974 C0398623 C1861171 C0020621 C0032827 C0034341 C0268125 C1971019 C3150275 C3151082 C0027051 C2926063 C0155668 C0428953 C0264708 C0155626 C1273976 C0746727 C2348362 C1168331 C0455406 C0340324 C1998297 C0340312 C0340325 C0428950 C2825159 C0439775 C0429067 C0429107 C0520886 C0018787 C0007430 C0018795 C0442893 C0679247 C2020636 C1161007 C0018787 C1306232 C0009450 C3714514 C0275524 C0012683 C0035637 C0276041 C0729555 C0747002 C0043031 C1601605 C1601620 C0087111 C0033972 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0043031 C1601605 C1601620 C0262926 C2004062 C1561538 C0087111 C0033972 C0040044 C3511525 C0519784 C0038418 C0042071 C1522670 C0032143 C0007436 C0041953 C1827740 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0018787 C3245491 C1552578 C0013230 C0220825 C1261322 C0304229 C0003280 C0161530 C0261806 C3536711 C0238662 C0354604 C0168273 C1314413 C0939677 C0018916 C1959588 C0040018 C0087086 C0863178 C1337342 C1552740 C1550472 C0007436 C0041953 C1827740 C0019134 C0770546 C0018787 C0424653 C1305866 C2053618 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0015811 C3842337 C0003842 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0003842 C0162868 C1510412 C0018944 C1962958 C2963140 C0752156 C3878495 C2230323 C0015801 C1280173 C0226448 C1281581 C0226455 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C1552850 C0042381 C0038897 C0740038 C0182437 C1964018 C0015811 C0015801 C1280173 C0226448 C1281581 C0226455 C3245511 C0449618 C0311395 C1456822 C2024884 C0239064 C0522034 C0022116 C0015385 C1140621 C1306232 C0231221 C0277899 C3714552 C0016504 C0034107 C0391850 C0004364 C0406632 C0400936 C0850560 C0577642 C0687719 C0015801 C1280173 C0226448 C1281581 C0226455 C0456642 C4068863 C3245501 C3245502 C0006675 C0012634 C0018609 C0038257 C1705817 C0441587 C0035139 C1555302 C1533810 C0012725 C0034117 C0033119 C0011121 C0740038 C0182437 C1964018 C0033119 C0034117 C0034117 C0033119 C0034117 C0033119 C0018944 C1962958 C0750138 C0042371 C0280956 C1299586 C0563560 C3842554 C0033119 C0034117 C0003842 C0189586 C1548740 C0176674 C0003842 C0042449 C0018246 C0947630 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0520997 C0087111 C0723712 C0723719 C1547427 C1868885 C0005823 C0005824 C1272641 C0020649 C0725357 C2230142 C0020538 C2926615 C0180208 C0428889 C0428886 C0488053 C0497247 C0015252 C0728940 C0018790 C1995642 C0012000 C0428883 C0085096 C0199686 C0553983 C0162819 C1261287 C0005847 C0003842 C0012634 C0018609 C0005847 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0009653 C0227952 C0442739 C0262185 C0856882 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0020517 C0489531 C1527304 C0719113 C0719656 C3247823 C3845898 C0019993 C3840878 C3841837 C3841838 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C3245501 C3245502 C3845898 C0543467 C1457907 C2081627 C0021860 C0702122 C2939463 C0178483 C0003842 C0948268 C0036980 C0013227 C2094204 C0802604 C2598133 C2081612 C0033045 C0007430 C0191117 C2025500 C2025504 C0398266 C0770826 C0237607 C0596545 C3845885 C1697779 C0699886 C0549206 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C2828358 C3668831 C3845898 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0020517 C0489531 C1527304 C0719113 C0719656 C3247823 C0009924 C3845898 C0013987 C0002978 C3272565 C0151576 C0151680 C0151872 C0151878 C0221106 C0235986 C0240292 C0520869 C0595879 C0856882 C0861002 C1295665 C1295668 C0340778 C1619636 C3245501 C3245502 ", "concepts": "Femoral Artery, Deep Femoral Artery, Hemostatic, Hemostat, FS Hemostatic, Closure, Site, Site summary, summary study, Evaluate angiograms, Angiogram, Angiogram, Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, Therapeutics, Therapeutic, therapeutic m, Therapeutic, Diagnostic, Diagnostic, Diagnostic, Diagnostic, untreated Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, Patient, Patient, Patient, Patient, Patient, Patient, 0 days, monitor, monitor, monitor description, prescription, prescription Complications, complications, Complications, complications iud, complications iud, NB complication, method, methods, elated, Unrelated hemostasis, secondary, Puncture, Puncture Complications, complications, Complications, complications iud, complications iud, NB complication, hemostasis, Puncture, Puncture, method, methods, minor, elated, Unrelated hemostasis, ambulation, Discharge, Discharge, Discharge, Discharge, Discharge secondary, Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure criteria, Eligibility Criteria informed consent form, galega, provider interventional, intervention, interventions, interventional CT, interventional MRI, coronary, Patient, Patient, Patient, Patient, Patient, Patient, schedule, Diagnostic, Diagnostic, Diagnostic, Diagnostic Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure Target vessel, 6 mm Patient, Patient, Patient, Patient, Patient, Patient, willing, Unwilling, fat requirements arterial puncture, Aterial puncture, Arterial puncture NEC, femoral arteries, Femoral artery, Left femoral artery, Left femoral artery, Deep femoral artery, Patient, Patient, Patient, Patient, Patient, Patient, common Criteria Arterial puncture, NOS, Aterial puncture, Arterial puncture NEC, femoral arteries, Femoral artery, Left femoral artery, Left femoral artery, Deep femoral artery, legs compression, decompression, Decompression, Impression, Manual, Manual, Arterial previous MI Arterial surgical repair, Microsurgical repair, blood vessel, Blood vessel, History, History, Arterial Patient, Patient, Patient, Patient, Patient, Patient, unable, Ambulate, Vaseline platelet dysfunction, Uremic platelet dysfunction, bleeding diathesis, Bleeding diathesis Thrombocytopenia NOS, Thrombocytopenia 1, Thrombocytopenia 2, Thrombocytopenia 4, Thrombocytopenia 3, Thrombocytopenia toxic, Thrombocytopenia, mild Anemia, Hct Haemophilia, Haemophilia, Hemophilia Bs, Hemophilia C, Hemophil disease, h disease, Von Willebrand Thrombophilia NOS, Thrombophilia V, k deficiency, k deficiency, PC deficiency, NP deficiency, Na deficiency, C2 deficiency, C8 deficiency Myocardial infarction, NOS, Myocardial infarction, Healed myocardial infarction, ECG: myocardial infarction, atrial myocardial infarction, Acute myocardial infarction, First myocardial infarction, septal myocardial infarction, Septal myocardial infarction, Apical myocardial infarction, FH: Myocardial infarction, Silent myocardial infarction, Recent myocardial infarction, Lateral myocardial infarction, Aborted myocardial infarction, ECG: no myocardial infarction, Date of myocardial infarction, elevation, PR elevation, TU elevation, ST elevation, cardiac catheterization procedure, heart catheterization procedure systemic disease, terminal illness, terminal illness, terminal illness care, cardiac, severed Infection, infections, Coinfections, Disinfection, RP infection, MG infection, GI infection, op infection warfarin, Narfarin, Marfarin, therapy, Cotherapy Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, warfarin, Narfarin, Marfarin, history, history, day therapy, Cotherapy Thrombolytic therapy, Thrombolytic art therapy, Thrombolytic therapy stroke, streptokinase, urokinase, Urokinase, t-PA peripheral catheterization, Ureteral catheterization, Peripheral catheter, Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, cardiac investigational, investigation, investigational drug, Investigation, Investigation, drug trial anticoagulant, Anticoagulants, Anticoagulants, Anticoagulant, anticoagulants use, oral anticoagulants, bivalirudin, Bivalirudin, Angiomax, Angioma, Angiomas, thrombin, thrombi, Thrombin, Thrombin, specific, low peripheral catheterization, Ureteral catheterization, Peripheral catheter, heparins, heparin, cardiac, weight, weight, weight Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure femoral, 0 days, Arterial Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, artery pseudoaneurysms, Pseudoaneurysms, hematomas, Hematoma, Arteriovenous fistula, dural arteriovenous fistula, Arteriovenous fistula kit, arteriovenous fistula on exam femoral arteries, Femoral artery, Left femoral artery, Left femoral artery, Deep femoral artery, Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, start vascular surgery, cardiovascular surgery, vascular graft, vascular grafts, Vascular grafts, femoral femoral arteries, Femoral artery, Left femoral artery, Left femoral artery, Deep femoral artery, common target vessel, claudications, claudication, claudications, Jaw claudication, Arm claudication, ischemia, limb, leg, severed, Asymptomatic absent pulse, weak pedal, pulse, pulse autoimmune disease, autoimmune diseases skin, autoimmune disease liver, other autoimmune disease, FH: Autoimmune disease, Autoimmune disease NEC femoral arteries, Femoral artery, Left femoral artery, Left femoral artery, Deep femoral artery, introducer, Tortuous, required, required calcium, disease, h disease, stents, stent placements, replacements, Replacement, Placement, Displacement, Puncture, Puncture Decontamination vascular graft, vascular grafts, Vascular grafts, Puncture, Puncture Puncture, Puncture Puncture, Puncture Hematomas, Hematoma vascular access, vascular access port, poor vascular access, Difficulty, Difficulty WB, No Difficulty, punctures, Punctures, Arterial arterial puncture, Aterial puncture, Arterial puncture NEC Arterial, Venous, groin study Patient, Patient, Patient, Patient, Patient, Patient thrombolysis, Therapeutics, Therapeutic, therapeutic m, Therapeutic Uncontrolled hypertension, Blood pressure, take blood pressure, blood pressures, low blood pressures, blood pressure kit, blood pressure leg, high blood pressure, High blood pressure, blood pressure cuff, Cuff blood pressure, mean blood pressure, Mean blood pressure, blood pressure rise, removals, removals Asystolic, Bystolic, Diastolic, diastolic BP Peripheral vascular disease (& [NOS]), Peripheral vascular disease study, Other peripheral vascular disease, peripheral vascular disease of skin, stenosis, vessel, Arterial disease, h disease, vessel Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, Sheath, Sheath, Unchanged act, elevated k Patient, Patient, Patient, Patient, Patient, Patient, allergy, allergy, allergy, Callergy, dallergy, Dallergy, Uknown hospitalization, Hospitalization 1, Hospitalization 3, Hospitalization 2, Patient, Patient, Patient, Patient, Patient, Patient, required, required, Uknown surgery, surgery, surgery: Intra-aortic balloon pump [IABP], Intra-aortic balloon pump device, Intra-aortic balloon pump, aortic balloon pump, Arterial hemodynamic instability, Cardiogenic shock, medications, medications:, Medications, Medications, medication:, Premedications catheterization, IVC catheterization, IVC catheterization, SVC catheterization, vein catheterization, catheterization kits, experience, experience, Inexperience, immediate, Mechanical pregnant, Patient, Patient, Patient, Patient, Patient, Patient, Lactating, Lactating, Uknown Patient, Patient, Patient, Patient, Patient, Patient, allergy, allergy, allergy, Callergy, dallergy, Dallergy, contrast media, Uknown feels, angiography, Clinical CK increased, LH increased, PT increased, QT increased, pH increased, GH increased, increased mg, CI increased, Na increased, K+ increased, Zn increased, T4 increased, T3 increased venous puncture, Required, required, required "}
